Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Lixisenatide on arterial stiffness in patients with diabetic nephropathy
2016-001758-17Phase 4Unknown
- Sponsor
- King's College London
- Start
- Sep 2016
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) and diabetic glomerulosclerosis comparing Lixisenatide with Placebo (2 arms). Primary endpoint: Change in aortic pulse wave velocity. Status: unknown.
02
Drugs
lixisenatide
03
Conditions
type 2 diabetes mellitus (T2DM)diabetic glomerulosclerosis
Beyond the preview
Go deeper on 2016-001758-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-001758-17.